(BUSINESS WIRE)– Exact Sciences Corp. (Nasdaq:EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) has published an updated 2015 Clinical …
William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), as the company announced a bought deal for 4 million shares of …
William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that UnitedHealth (NYSE:UNH) issued an updated medical policy on …
In a research report released Wednesday, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following the news that the Centers …
Wedbush analyst Zarak Khurshid maintained a Neutral rating on Exact Sciences Corp (NASDAQ:EXAS) with a price target of $19, which represents a potential …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Exact Sciences (NASDAQ:EXAS) with a price target of …
In a research report sent to investors today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that …
In a research report released Friday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Exact Sciences (NASDAQ:EXAS) and raised his price target to …
